People in the News

Premium

Accelrys has disclosed in a filing with the US Securities and Exchange Commission that Steven Goldby, a member of the company’s board of directors, will not stand for re-election at the end of his current term.

Goldby notified Accelrys of his decision last month. The company said his decision was based on personal reasons and did not involve any disagreement with the Accelrys operations, policies or practices. He will continue to perform his duties until his term expires later this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.